MRNA stock closes down 6.55% but remains above daily EMAs
Photo: The Cryptonomist
MRNA stock has a bullish daily structure, but the shorter timeframes offer only partial confirmation. Moderna ‘s completed session ended below the daily pivot for the next session, while remaining above its daily exponential averages. The central question is whether that longer-term support can outweigh conflicting short-term momentum signals. Key takeaways MRNA stock ended Thursday’s session at $241.46 , down 6.55% from the prior close of $258.38. The daily 20-session EMA at $219.68 remains above the 50-session EMA at $188.93 and the 200-session EMA at $110.31.
Source: The Cryptonomist
